Cited by 79Alzheimer's disease research and treatmentsSphingolipid Metabolism and SignalingDementia and Cognitive Impairment Research

Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer’s disease

Open access
Cheng, Hua, Zhou, Yunhua, Holtzman, David M., Han, Xianlin·2010·Neurobiology of Aging

Abstract

Herein, we tested a recently proposed working model of apolipoprotein E (apoE)-mediated sulfatide metabolism/trafficking/homeostasis with two well-characterized amyloid precursor protein (APP) transgenic (Tg) animal models of Alzheimer's disease (AD) (i.e., APP(V717F) and APPsw) on a wild-type murine apoE background or after being bred onto an Apoe(-/-) background. As anticipated, lipidomics analysis demonstrated that the sulfatide levels in brain tissues were reduced beginning at approximately 6 months of age in APP(V717F) Tg, Apoe(+/+) mice and at 9 months of age in APPsw Tg, Apoe(+/+) mice relative to their respective non-APP Tg littermates. This reduction increased in both APP Tg mice as they aged. In contrast, sulfatide depletion did not occur in APP Tg, Apoe(-/-) animals relative to the Apoe(-/-) littermates. The lack of sulfatide depletion in APP Tg, Apoe(-/-) mice strongly supports the role of apoE in the deficient sulfatide content in APP Tg, Apoe(+/+) mice. Collectively, through different animal models of AD, this study provides evidence for an identified biochemical mechanism that may be responsible for the sulfatide depletion at the earliest stages of AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2008.07.020

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 33

  1. Arelin K Kinoshita A Whelan CM Irizarry MC Rebeck GW Strickland DK Hyman BT 2002 LRP and senile plaques in Alzheimer’s disease: colocalization with apolipoprotein E and with activated astrocytes Brain Res Mol Brain Res 104 38 46 12117549
  2. Bales KR Dodart JC DeMattos RB Holtzman DM Paul SM 2002 Apolipoprotein E, amyloid, and Alzheimer disease Mol Interv 2 363 375 14993413
  3. Bosio A Binczek E Stoffel W 1996 Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis Proc Natl Acad Sci USA 93 13280 13285 8917582 PMC24084
  4. Bosio A Bussow H Adam J Stoffel W 1998 Galactosphingolipids and axono-glial interaction in myelin of the central nervous system Cell Tissue Res 292 199 210 9560463
  5. Cheng H Xu J McKeel DW Jr Han X 2003 Specificity and potential mechanism of sulfatide deficiency in Alzheimer’s disease: An electrospray ionization mass spectrometric study Cell Mol Biol 49 809 818 14528918
  6. Cheng H Guan S Han X 2006 Abundance of triacylglycerols in ganglia and their depletion in diabetic mice: Implications for the role of altered triacylglycerols in diabetic neuropathy J Neurochem 97 1288 1300 16539649 PMC2137160
  7. Cheng H Jiang X Han X 2007 Alterations in lipid homeostasis of mouse dorsal root ganglia induced by apolipoprotein E deficiency: A shotgun lipidomics study J Neurochem 101 57 76 17241120 PMC2137162
  8. Coetzee T Fujita N Dupree J Shi R Blight A Suzuki K Popko B 1996 Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability Cell 86 209 219 8706126
  9. Coetzee T Dupree JL Popko B 1998 Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice J Neurosci Res 54 613 622 9843152
  10. Fryer JD Taylor JW DeMattos RB Bales KR Paul SM Parsadanian M Holtzman DM 2003 Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice J Neurosci 23 7889 7896 12944519 PMC6740607
  11. Games D Adams D Alessandrini R Barbour R Berthelette P Blackwell C Carr T Clemens J Donaldson T Gillespie F Guido T Hagopian S Johnson-Wood K Khan K Lee M Leibowitz P Lieberburg I Little S Masliah E McConlogue L Montoya-Zavala M Mucke L Paganini L Penniman E Power M Schenk D Seubert P Snyder B Soriano P Tan H Vitale J Wadsworth S Wolozin B Zhao J 1995 Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein Nature 373 523 527 7845465
  12. Gearing M Schneider JA Robbins RS Hollister RD Mori H Games D Hyman BT Mirra SS 1995 Regional variation in the distribution of apolipoprotein E and A beta in Alzheimer’s disease J Neuropathol Exp Neurol 54 833 841 7595656
  13. Han X Cheng H Fryer JD Fagan AM Holtzman DM 2003a Novel role for apolipoprotein E in the central nervous system: Modulation of sulfatide content J Biol Chem 278 8043 8051 12501252
  14. Han X Fagan AM Cheng H Morris JC Xiong C Holtzman DM 2003b Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia Ann Neurol 54 115 119 12838527
  15. Han X Yang J Cheng H Ye H Gross RW 2004 Towards fingerprinting cellular lipidomes directly from biological samples by two-dimensional electrospray ionization mass spectrometry Anal Biochem 330 317 331 15203339
  16. Han X Gross RW 2005 Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of the cellular lipidomes directly from crude extracts of biological samples Mass Spectrom Rev 24 367 412 15389848
  17. Han X 2007 Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stages of Alzheimer’s disease: a tale of shotgun lipidomics J Neurochem 103 s1 171 179 17986152 PMC2147059
  18. Holtzman DM Bales KR Tenkova T Fagan AM Parsadanian M Sartorius LJ Mackey B Olney J McKeel D Wozniak D Paul SM 2000a Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer’s disease Proc Natl Acad Sci USA 97 2892 2897 10694577 PMC16026
  19. Holtzman DM Fagan AM Mackey B Tenkova T Sartorius L Paul SM Bales K Ashe KH Irizarry MC Hyman BT 2000b Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer’s disease model Ann Neurol 47 739 747 10852539
  20. Hsiao K Chapman P Nilsen S Eckman C Harigaya Y Younkin S Yang F Cole G 1996 Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 99 102 8810256
  21. Irizarry MC Soriano F McNamara M Page KJ Schenk D Games D Hyman BT 1997b Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse J Neurosci 17 7053 7059 9278541 PMC6573263
  22. Jiang X Cheng H Yang K Gross RW Han X 2007 Alkaline methanolysis of lipid extracts extends shotgun lipidomics analyses to the low abundance regime of cellular sphingolipids Anal Biochem 371 135 145 17920553 PMC2131739
  23. Kuo YM Crawford F Mullan M Kokjohn TA Emmerling MR Weller RO Roher AE 2000 Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer’s disease Mol Med 6 430 439 10952022 PMC1949958
  24. Marcus J Honigbaum S Shroff S Honke K Rosenbluth J Dupree JL 2006 Sulfatide is essential for the maintenance of CNS myelin and axon structure Glia 53 372 381 16288467
  25. Molander-Melin M Pernber Z Franken S Gieselmann V Mansson JE Fredman P 2004 Accumulation of sulfatide in neuronal and glial cells of arylsulfatase A deficient mice J Neurocytol 33 417 427 15520527
  26. Nagy Z 2005 The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer’s disease J Cell Mol Med 9 531 541 16202202 PMC6741636
  27. Pernber Z Molander-Melin M Berthold CH Hansson E Fredman P 2002 Expression of the myelin and oligodendrocyte progenitor marker sulfatide in neurons and astrocytes of adult rat brain J Neurosci Res 69 86 93 12111819
  28. Van Uden E Kang DE Koo EH Masliah E 2000 LDL receptor-related protein (LRP) in Alzheimer’s disease: towards a unified theory of pathogenesis Microsc Res Tech 50 268 272 10936878
  29. von Figura K Gieselmann V Jaeken J Sachdev HS Beaudet AL Sly WS Valle D 2001 Metachromatic leukodystrophy: Lysosomal disorders The metabolic and molecular bases of inherited diseases 8 New York McGraw-Hill 3695 3724
  30. Vos JP Lopes-Cardozo M Gadella BM 1994 Metabolic and functional aspects of sulfogalactolipids Biochim Biophys Acta 1211 125 149 8117740
  31. Yang K Zhao Z Gross RW Han X 2007 Shotgun lipidomics identifies a paired rule for the presence of isomeric ether phospholipid molecular species PLoS ONE 2 e1368 18159251 PMC2147047
  32. Zeng Y Cheng H Jiang X Han X 2008 Endosomes and lysosomes play distinct roles in sulfatide-induced neuroblastoma apoptosis: Potential mechanisms contributing to abnormal sulfatide metabolism in related neuronal diseases Biochem J 410 81 92 17939778
  33. Zeng Y Han X 2008 Sulfatides facilitate apolipoprotein E-mediated amyloid-b peptide clearance through an endocytotic pathway J Neurochem 10.1111/j.1471-4159.2008.05481.x PMID: 18485101 PMC2574953 18485101 · DOI

Cited by

Sorted by citations

Authors
Cheng, H., Zhou, Y., Holtzman, D. M., & Han, X.
Affiliations
  • Washington University in St. Louis (US)
  • Chinese Academy of Sciences (CN)
Corresponding author
Han, Xianlin
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2010-07
Volume
31
Issue
7
Pages
1188-1196
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2091782008
Cited by
79
References
5
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 4 · 2021: 12 · 2020: 7 · 2019: 2 · 2018: 9 · 2017: 7 · 2016: 3 · 2015: 2 · 2014: 1 · 2013: 5 · 2012: 2
FWCI
2.26
Type
journal article
Language
en
Open access
Locations
  • Neurobiology of Aging (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Aging (R01AG031675, R01 AG23168, R01AG023168, R01AG013956, R01AG-31675, R37AG013956, AG13956)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
apolipoprotein E, sulfatide, Alzheimer's disease, amyloid precursor protein transgenic mice, sulfatide metabolism, lipidomics, ApoE-deficient mice
MeSH terms
Alzheimer Disease, Animals, Apolipoproteins E, Brain, Brain Chemistry, Disease Models, Animal, Homeostasis, Lipoproteins, Mice, Transgenic, Models, Biological, Myelin Sheath, Sphingomyelins, Sulfoglycosphingolipids, Down-Regulation, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Mice, Knockout, Lipid Metabolism, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review